Allspring Global Investments
THRD

Allspring Global Investments’s Third Harmonic Bio THRD Stock Holding History

Allspring Global Investments’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7,309
Closed -$46.7K – 2721
2023
Q3 		$46.7K Buy
7,309
+6,977
+2,102% +$42.6K ﹤0.01% 2292
2023
Q2 		$1.6K Buy
+332
New +$1.58K ﹤0.01% 2642

Other funds holding THRD

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Allspring Global Investments's THRD Position: Q4 2023 in Review

Allspring Global Investments sold out of Third Harmonic Bio (THRD) in Q4 2023, closing a stake of 7,309 shares — an estimated $46.7K sold.

Allspring Global Investments first reported a position in THRD in Q2 2023 and held it in 2 quarters. The position peaked at $46.7K in Q3 2023. 62 funds tracked by Wall St. Rank hold THRD as of Q4 2023.

  • Allspring Global Investments reported no remaining Third Harmonic Bio position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 7,309 Third Harmonic Bio shares in Q4 2023, an estimated $46.7K.
  • Allspring Global Investments first reported a position in Third Harmonic Bio in Q2 2023 and held it in 2 quarters.
  • Allspring Global Investments's Third Harmonic Bio position peaked at $46.7K in Q3 2023.
  • 62 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.